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Inhibitory interneurons are an important component of dorsal horn circuitry where they serve to modulate spinal
nociception. There is now considerable evidence indicating that reduced inhibition in the spinal dorsal horn
contributes to neuropathic pain. A loss of these inhibitory neurons after nerve injury is one of the mechanisms
being proposed to account for reduced inhibition; however, this remains controversial. This is in part because
previous studies have focused on global measurements of inhibitory neurons without assessing the number of
inhibitory synapses. To address this, we conducted a quantitative analysis of the spatial and temporal changes in
the number of inhibitory terminals, as detected by glutamic acid decarboxylase 65 (GAD65) immunoreactivity, in
the superficial dorsal horn of the spinal cord following a chronic constriction injury (CCI) to the sciatic nerve in rats.
Isolectin B4 (IB4) labelling was used to define the location within the dorsal horn directly affected by the injury to
the peripheral nerve. The density of GAD65 inhibitory terminals was reduced in lamina I (LI) and lamina II (LII) of the
spinal cord after injury. The loss of GAD65 terminals was greatest in LII with the highest drop occurring around 3–4
weeks and a partial recovery by 56 days. The time course of changes in the number of GAD65 terminals correlated
well with both the loss of IB4 labeling and with the altered thresholds to mechanical and thermal stimuli. Our
detailed analysis of GAD65+ inhibitory terminals clearly revealed that nerve injury induced a transient loss of GAD65
immunoreactive terminals and suggests a potential involvement for these alterations in the development and
amelioration of pain behaviour.
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interneurons, Synaptic boutonsIntroduction
Neuropathic pain is a debilitating condition that arises as a
“direct consequence of a lesion or disease affecting the
somatosensory system” [1]. Nerve injury is accompanied by
many alterations in the dorsal horn of the spinal cord which
play a role in driving and maintaining the accompanying
pain. One such alteration that remains controversial is the* Correspondence: alfredo.ribeirodasilva@mcgill.ca
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unless otherwise stated.question of whether or not inhibitory interneurons in the
dorsal horn are lost in conditions of pain [2,3]. This is an
important question to resolve, as these inhibitory inter-
neurons play an important role in modulating sensory in-
formation before it is forwarded to higher brain centers.
Most pain related information is forwarded from the
periphery to the central nervous system by unmyelinated
primary afferents (C fibres) called nociceptors. They have
been divided into two roughly distinct populations based
on neurochemical and anatomical criteria: the peptidergic
and non-peptidergic C fibres [4-7]. Of particular interest
to this study are the non-peptidergic C fibres which bind
the isolectin B4 (IB4), express purinergic P2X3 receptorsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Lorenzo et al. Molecular Pain 2014, 10:57 Page 2 of 12
http://www.molecularpain.com/content/10/1/57and possess fluoride-resistant acid phosphatase activity
[6]. These non-peptidergic fibres terminate primarily in
inner lamina II (LIIi) of the dorsal horn in complex synap-
tic glomeruli, where they represent the central element
and are often postsynaptic to inhibitory interneurons
[8-10]. After peripheral injury of the sciatic nerve, IB4-
binding is lost and subsequently restored in both the dor-
sal root ganglia [11] and in the spinal cord [12-15]. The
loss of IB4 binding in the dorsal horn corresponds to a
bona fide loss of the central terminals of non-peptidergic
fibres, as confirmed by electron microscopy (EM) [13], in-
dicating the reliability of this marker.
Inhibitory interneurons represent an important compo-
nent of dorsal horn circuitry, and form close associations
with non-peptidergic fibres. The inhibitory neurotrans-
mitter γ-aminobutyric acid (GABA) is synthesized from
glutamate by the enzyme glutamic acid decarboxylase
(GAD), and both neurotransmitter and enzyme are found
in these inhibitory interneurons. Two distinct isoforms of
GAD exist; GAD 67 and GAD 65 and each is encoded for
by a different gene, gad1 and gad2, respectively [16]. In
the brain, whereas GAD67 is a cytosolic enzyme that is
widely distributed throughout the neuron and often labels
cell bodies, GAD65 predominantly localizes to the nerve
terminal [17,18]. This differential pattern of staining does
not seem to be true in the spinal cord where most axon
terminals contain both isoforms [19]. This said, the pre-
dominance of each isoform is suggested to vary based on
laminar location, with LI and LII containing significantly
more inhibitory profiles that largely express GAD65 than
deeper laminae, where GAD67 staining is stronger [19].
Recently, GAD65 was shown to be directly implicated
in pain mechanisms, as GAD65 knockout mice show
impaired synaptic inhibition and sensitized pain be-
haviour [20].
Neuronal apoptosis in the dorsal horn has been re-
ported in models of neuropathic pain, and it has been
suggested that inhibitory interneurons are among the
neurons lost [3,21-24]. As mentioned, this loss of dorsal
horn inhibitory neurons remains controversial as others
propose that it is primarily microglia [25] and not inhibi-
tory neurons that undergo apoptosis [2,25,26]. Regardless
of whether or not there is a loss of neurons, remaining in-
hibitory neurons could either compensate by increasing
their number of synaptic profiles or conversely, could
shrink by reducing their synaptic connectivity. One way of
clarifying the effect of nerve injury on inhibitory neurons
in the dorsal horn is to perform a proper quantification of
inhibitory terminals. Accordingly, this study was designed
to investigate if the number of GAD65-immunoreactive
(IR) boutons was altered following a chronic constriction
injury (CCI) by means of a polyethylene cuff in rat. IB4 la-
belling was used as a tool to define the area of the spinal
dorsal horn where the afferents affected by the nerveinjury terminate and allowed us to quantify the number
of GAD65-IR boutons within the area of lesion of IB4
fibres in lamina II (LII) and in adjacent lamina I (LI).
Pain-related behaviour was assessed concomitantly with
changes in synaptic terminal density. While some stud-
ies have examined global changes in GAD expression
throughout the spinal cord [3,22,27], this is the first
to demonstrate changes in the number of GAD65-IR
boutons, in the region of loss of nociceptive primary
afferents at different time points post nerve injury.
Results
Behaviour
All of the rats that had undergone cuff surgery exhibited
alterations in ipsilateral hind paw posture. Cuff, but not
sham animals, held their affected paw in an everted pos-
ition with the toes plantar-flexed, and avoided bearing
weight on it. To facilitate a direct comparison of nocicep-
tive behaviour between sham and cuff animals, all behav-
ioural assessments were normalized to sham controls,
with statistics performed on absolute values. Following
cuff surgery, animals showed a progressive reduction in
paw withdrawal threshold to mechanical stimuli. Test re-
sults for mechanical sensitivity are shown in Figure 1A.
Ipsilateral to injury, paw withdrawal thresholds (as mea-
sured by 50% von Frey withdrawal threshold), decreased
starting the 5th day post cuff application, and were signifi-
cantly different from sham ipsilateral thresholds by
14 days. Mechanical sensitivity reached its maximum
21 days post cuff application when mechanical thresholds
were only 16.3 ± 2.6% of sham ipsilateral values. Gradually,
thresholds returned to sham levels by 56 days. Cuff contra-
lateral and sham contralateral withdrawal thresholds were
not significantly different at any of the time points tested,
demonstrating a lack of bilateral hypersensitivity to mech-
anical stimuli (data not shown).
In addition to changes in mechanical thresholds, animals
showed a decrease in withdrawal latencies to a noxious
thermal stimulus. Test results for thermal hyperalge-
sia, measured using the Hargreaves method, are shown in
Figure 1B. Starting 5 days after surgery, withdrawal laten-
cies of the ipslateral hindpaw declined steadily, and were
significantly different when compared to sham ipsilat-
eral control values at 21 days. Heat hyperalgesia was
maximal at 28 days, when thermal thresholds were
only 70.1 ± 4.6% of sham ipsilateral values. Like mech-
anical hyperalgesia, thermal hyperalgesia was still
present at day 42 post-surgery and returned only to
sham levels by 56 days. Withdrawal latencies decreased
slightly contralateral to injury, but were significantly dif-
ferent from cuff ipsilateral values at day 21 post-surgery.
Cuff contralateral and sham contralateral withdrawal
thresholds were not significantly different at any of the
time points tested (data not shown).
Mechanical Von Frey testing



























































































Figure 1 Behavioural changes following application of the cuff. Results for the ipsilateral hindpaws are shown for both neuropathic (n = 10)
and sham-operated (n = 10) Wistar rats while the contralateral values are shown for neuropathic rats only. Each point represents the mean ± SEM
as a percentage of sham values (percentage of sham ipsilateral hindpaw for neuropathic ipsilateral results and percentage of sham contralateral
hindpaw for neuropathic contralateral results). A) 50% withdrawal threshold to von Frey hairs in neuropathic and sham-operated rats as a
percentage of sham values obtained with the up-down method. B) Assessment of thermal hyperalgesia using the Hargreaves’ test. Withdrawal
threshold to light stimulus as a percentage of sham values. In A and B, comparison to sham ipsilateral hindpaw *P < 0.05, **P < 0.01 by 2 way ANOVA
with Bonferroni correction. Comparison to contralateral hindpaw of cuff animals #P < 0.05, ##P < 0.01.
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To investigate the changes in GAD65-IR inhibitory termi-
nals in the superficial dorsal horn, a double labelling was
performed at various time points after cuff application
using a monoclonal antibody directed against GAD65
combined with IB4 conjugated to a fluorochrome. The
IB4 labelling was used as a tool to define the location of
the lesion that occurs in the dorsal horn after CCI. In thisway, the changes in GAD65-IR inhibitory terminals could
be quantified in the region where the majority of IB4 fi-
bres terminate, LII, and outside this region, in LI. Mor-
phological studies were performed at 5, 7, 10, 14, 21, 42
and 56 days, allowing us to study the onset of changes, as
we had many early time points, and allowed us to discrim-
inate a time at which markers returned to near normal
using the 2 later time points. Figure 2 shows representative
Figure 2 Representative confocal microscopy images of IB4 and GAD65 immunoreactivity in the dorsal horn of sham (A-D) and
neuropathic (E-H) rats ipsilateral to injury at 5, 7, 10 and 14 days after surgery. Capital letters and lowercase letters denote images taken
with 20X and 63X objectives, respectively. Lowercase italic letters show representative images of quantified regions in both lamina I and lamina II,
taken with a 63X objective and a zoom factor of 2. IB4-labeling is shown in green and GAD65 in red. Note that for each time point, the image
with the largest loss of IB4 staining was chosen for illustration and this IB4 lesion is shown by a yellow rectangle. The smaller regions used for
quantification were taken from within these yellow rectangles. In sham animals, IB4 labelling was primarily restricted to a thin band in lamina II,
whereas GAD65 labelling was observed throughout the dorsal horn. GAD65-IR boutons were readily observed among the IB4-labelled terminals.
Starting at 5 days after surgery (E) but more clearly visible from day 7 (F) there was a region of depletion of IB4 staining that was not observed
in sham animals at any time point (A-D). High magnification images of neuropathic rats show a clear lack of IB4 staining in lamina II from days 7
(f and f) to 14 (h and h).GAD65-IR boutons are reduced in cuff animals (e-h) compared to sham animals (a-d).
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cation 2A-D, high magnification 2a-d) and cuff animals
(low magnification 2E-H, high magnification 2e-h) 5, 7, 10
and 14 days after surgery, while images taken at days 21,
42 and 56 are shown in Figure 3 (sham 3A-C, 3a-c; cuff
3D-F, 3d-f). Panels labelled with lowercase italic letters
(Figure 2a-h and Figure 3a-f) show representative images
of the high magnification regions in both lamina I and II
that were used for quantification. In these images, GAD65
terminals in red and IB4 terminals in green are most
clearly visible.
In sham-operated animals, IB4-binding was mostly re-
stricted to LII, with much less labelling in lamina I. Labelling
was particularly intense in LIIi (Figures 2A-D and 3A-C).At greater magnification, IB4 binding was seen to be con-
centrated in varicosities (Figures 2a-d and 3a-c). Cell bod-
ies were not labelled. Contrary to IB4 labelling, GAD65
immunoreactivity was observed throughout the entire
dorsal horn and its punctate appearance was evident at
high magnification (Figures 2a-d and 3a-c). Although
some of the structures we name as varicosities certainly
represent GABAergic presynaptic dendrites [9], they can-
not be distinguished from GABAergic axonal varicosities
by light microscopy. All punctate GAD65-IR structures
larger than 0.05μm2 were counted, to avoid as much as
possible counting cut axons as varicosities or terminals.
Beginning as soon as 5 days post-surgery, cuff animals
exhibited a decrease in IB4-labelled (IB4+) varicosities
Figure 3 Representative confocal microscopy images of IB4 staining and GAD65 immunoreactivity from the dorsal horn of sham (A-C)
and neuropathic (D-F) rats ipsilateral to injury at 21, 42, 56 days after surgery. Capital letters and lowercase letters denote images taken
with 20X and 63X objectives, respectively. Lowercase italic letters show representative images of quantified regions in both lamina I and lamina II,
taken with a 63X objective, and a zoom factor of 2. IB4-labelling is shown in green and GAD65 in red. Note that for each time point, the image
with the largest loss of IB4 staining was chosen for illustration and this IB4 lesion is shown by a yellow rectangle. The smaller regions used for
quantification were taken from within these yellow rectangles. High magnification images show a clear lack of IB4+ terminals and an important
loss of GAD65-IR in lamina II at 21 days (d and d) in neuropathic animals. By 42 days (e and e) after surgery, IB4-IR and GAD65-IR began to be
restored in the lesion, however by 56 days (f and f) there were still considerably fewer IB4+ terminals present when compared to sham (c and c).
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loss of IB4 binding ("lesion" zone, delineated with a yel-
low rectangle) was most evident in the middle of LII, or
more precisely in the intermediate third of the medio-
lateral extent of the dorsal horn (Figure 2H), which cor-
responds to the spinal cord projection of the sciatic
nerve [28]. The density of IB4+ terminals in this region
of LII was quantified over time in cuff and sham animals
and the results are displayed in Figure 4A. Values for the
ipsi- and contralateral paws have been normalized to
those from sham controls, while statistical analysis was
performed using absolute values. Ipsilateral to injury, the
density of IB4+ terminals in LII was significantly decreased
at all time points studied when compared to sham controls
and to the side contralateral to injury. From 5 days, the
number of IB4+ profiles progressively declined and reached
a minimum at 21 days (Figure 3D), when the IB4+ vari-
cosity density ipsilateral to injury was 1.5 ± 0.3% of sham
controls. Gradually over the next 5 weeks, the density of
IB4+ terminals increased; however, an area of depletion
was still present at 56 days (Figure 3F) when the density of
IB4+ terminals reached only 52.1 ± 14.2% of sham controls.The density of GAD65-IR terminals in LII is displayed
in Figure 4B. Cuff application decreased the density of
GAD65-IR terminals ipsilateral to injury. While there
was a small decrease in the density of GAD65-IR termi-
nals at 5 and 7 days after CCI, it was only at 10 days that
the number of GAD65-IR terminals was significantly re-
duced within the area of IB4+ depletion in LII, when
compared with sham controls and to the side contralat-
eral to injury. As seen with IB4, a maximum reduction
in GAD65-IR terminals occurred at 21 days, where the
density reached 34.1 ± 8.5% of sham controls. While a stat-
istical recovery of GAD65 terminals occurred at 42 days
when compared to controls, at 56 days a small, albeit sig-
nificant reduction in the number of GAD65-IR varicosities
was still present as density was 72 ± 4.5% of sham levels.
The density of GAD65-IR terminals was also quantified
in LI (Figure 4C), a region which is much less innervated
by non-peptidergic fibres [10,29,30]. From 5 days, the
number of GAD65-IR varicosities progressively declined
and reached a minimum at 21 days, when their density ip-
silateral to injury was 63.1 ± 7.7% of sham controls. The
reduction in GAD65-IR terminals in LI (63.1 ± 7.7%) was
Figure 4 Quantitative analysis of the number of boutons in the
superficial dorsal horn of the spinal cord in sham and
neuropathic rats at various times after surgery. Quantification of
terminal density was performed within the region of loss of IB4
staining. The number of ipsilateral profiles is shown for neuropathic
and sham rats, with contralateral values shown only for neuropathic
animals. Each point represents the mean ± SEM as a percentage of
sham values. A) Quantitative analysis of the density of IB4-labelled
terminals in lamina II in sham and neuropathic rats. Neuropathic rats
had a drastic reduction in the number of IB4+ terminals ipsilateral to
injury with maximal loss occurring at 21 days followed by a gradual
recovery with numbers remaining significantly different from sham
at 42, 56 days. There were always significantly fewer IB4+ terminals
ipsilateral vs. contralateral to injury. B) Quantitative analysis of
GAD65-IR terminals in lamina II in sham and neuropathic rats.
Neuropathic rats had a progressive reduction in the number of
GAD65-IR terminals ipsilateral to injury with significantly fewer
profiles than sham at 10 days, and a maximal loss at 21 days.
Despite a partial recovery, GAD65-IR terminals remained significantly
reduced at 56 days compared to sham, and at 10, 14, 21, and 56 days
were significantly lower than contralateral values. C) Quantitative
analysis of GAD65-IR terminals in lamina I in sham and neuropathic
rats. Neuropathic rats had a small but progressive reduction in the
number of GAD65-IR terminals ipsilateral to injury with values
significantly different from sham at 10, 14 and 21 days and recovery by
42 days. There was a similar loss of GAD65-IR terminals ipsilateral and
contralateral to injury. *P < 0.05, **P < 0.01 sham ipsilateral vs.
neuropathic ipsilateral #P < 0.05 neuropathic ipsilateral vs. contralateral.
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a similar though much less marked trend was observed, as
the density of GAD65-IR terminals in LI was not signifi-
cantly different between ipsilateral and contralateral sides
at days 5, 7, 10, 14, 21, and 56 days.
A non-parametric Spearman correlation was performed
to determine if there is a relationship between the loss of
IB4+ terminals and the loss of GAD65+ varicosities in LII.
To do this, IB4+ bouton mean density was correlated to
their corresponding GAD65+ bouton mean density value
in every animal. Interestingly, in the density decreasing
phase of both entities, the density of IB4+ terminals was
significantly correlated with the density of GAD65-IR ter-
minals from 5 to 14 days along the four time points stud-
ied (5, 7, 10, 14 day; r = −0.4, p = 0.048, n = 25). As IB4
terminal density decreased, so did GAD65 density; how-
ever, this correlation was not observed in the “recovery
phase” of the two markers (from day 21 to 56; r = 0.09,
p = 0.73, n = 16).
Discussion
In this study, the time-dependant changes in the number
of GAD65-IR inhibitory terminals were examined in the
superficial dorsal horn of the rat spinal cord following
polyethylene cuff induced CCI of the sciatic nerve. Using
specific markers, and restrictive quantification techniques,
we show conclusively that cuff application results in a sig-
nificant but transient loss of GAD65 immunoreactivity,
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loss of IB4+ boutons in LII and, dorsal to it, in LI. The
early time-course of the loss of GAD65-IR terminals cor-
related well with the loss of IB4+ terminals in LII. Further-
more, the pattern of alterations in terminal densities
paralleled the changes in thresholds to both mechanical
and thermal stimuli.
It is well known that loss of GABAergic or glycinergic
inhibition in the dorsal horn leads to allodynia in naive
rats [31], and that loss of inhibitory tone in the dorsal
horn might underlie symptoms of neuropathic pain [32].
In light of these results, many studies have explored the
mechanisms which might contribute to this altered
neurotransmission. Of particular interest was the question
of whether or not nerve injury resulted in a loss of inhibi-
tory interneurons. Conflicting evidence quickly emerged.
Some studies suggested that GABAergic interneurons
were lost after nerve injury as indicated by a loss of GABA
immunoreactivity in the dorsal horn [23,24,27] and the
presence of apoptotic markers [3,21,22] while other stud-
ies using stereological counts opposed these results by
showing that neurons in LI-III were not lost after either
CCI [2,26] or spared nerve injury (SNI) [25]. Independent
of a change in the number of GABAergic cells following
injury, it is likely that they either retract or extend their
distal processes, a phenomenon that has been well de-
scribed in hippocampal neurons after stress [33].
In this study, GAD65 was used to visualize inhibitory
terminals by immunofluorescence and to clarify the ef-
fect of nerve injury on inhibitory neurons in the dorsal
horn. GAD65 was chosen for a number of reasons. 1. It
primarily localizes to nerve terminals [17-19]. 2. In lam-
inae I and II, where this study was focused, inhibitory
profiles with high levels of GAD65 are relatively com-
mon; this is not the case in more ventral laminae where
profiles with high levels of GAD67 dominate [19]. 3.
GAD65 knockout mice have impaired GABA synaptic
function and a lower baseline pain threshold indicating a
direct role for this isoform in both inhibition and pain
[20]. Using software parameters that specifically allowed
puncta the size of GABAergic boutons with a minimal
staining intensity to be counted as inhibitory terminals,
we have clearly shown that the density of GAD65+ in-
hibitory terminals was reduced in the ipsilateral superfi-
cial dorsal horn of the spinal cord after cuff injury. The
loss of GAD65-IR inhibitory terminals was not constant
over time or space. The loss of inhibitory terminals was
most significantly reduced at 3–4 weeks and recovered
partially by 56 days. Furthermore, the loss of GAD65-IR
terminals was greatest in LII, the region where the
majority of IB4+ fibres terminate and are lost after
nerve injury.
The finding that GAD65-IR density is temporally al-
tered by nerve injury is consistent with a number ofcomplementary findings. Meisner et al. [22] showed that
GAD65/67 immunoreactivity in the dorsal horn is re-
duced at 8 weeks after spinal cord injury (SCI), as are
the protein levels of GAD67 and GAD65 at 6 weeks.
Moore et al. [3] showed using Western blot that GAD65
protein is transiently reduced in the ipsilateral dorsal
horn by CCI and SNI; however, unlike us, they saw a full
restoration of GAD65 levels at 4 weeks post CCI. These
immunoblotting approaches used only provide a global
assessment of GAD protein levels in the entire ipsilateral
dorsal horn and likely do not reflect what is happening in
LI and LII, regions important in nociceptive transmission.
Finally, Eaton et al. [27] show that GAD67-IR cell bodies
in LI-III initially decrease in number 3 days post CCI but
begin to increase, eventually surpassing levels in intact an-
imals at 8 weeks after nerve injury. The different time-
course seen in this study is most likely attributable to the
fact that cell bodies, rather than terminals, were counted.
The major advantage of our study over the previous stud-
ies is that we were able to specifically quantify the number
of inhibitory terminals at various time points, within the
specific area in the spinal dorsal horn where the afferents
affected by the nerve injury terminate.
It is possible that the loss of GAD65 immunoreactivity
does not necessarily reflect a loss of inhibitory terminals,
but instead simply a down regulation of the protein. Be-
cause it has been shown that some boutons in the super-
ficial dorsal horn express high levels of GAD65 and low
levels of GAD67 [19], it is possible that these boutons
would be unable to synthesize GABA after GAD65 down-
regulation, effectively rendering these synapses non-
functional (as far as GABAergic transmission is concerned).
One limitation of the current study is that we investigate
the changes in GAD65 immunoreactivity only, and do not
consider GAD67. While some studies suggest that GAD65
is more dramatically reduced [3], others report that GAD65
and 67 are similarly decreased by nerve injury [22]. If
GAD67 is unchanged or even up regulated, some inhibitory
synapses could remain functional. Contrary to this, the fre-
quency of inhibitory postsynaptic currents (mIPSCs) is re-
duced by CCI [3] and in GAD65 knockout animals [20],
indicating that inhibitory neurons release less GABA in
these models. To more globally assess the entire GABAer-
gic inhibitory terminal population in neuropathic pain, anti-
bodies against GAD67 could be used in combination with
those against GAD65 or even by using antibodies that in-
discriminately recognize both isoforms. Alternatively, the
vesicular GABA transporter (VGAT), which acts as an ana-
tomical marker for inhibitory terminals [34,35], could be
used.
One of the most interesting and relevant findings of this
study is that the behavioural results matched well with the
loss and recovery of both IB4+ and GAD65-IR terminals.
As the density of both IB4+ fibre terminals and GAD65-
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tivity to both mechanical and thermal stimuli increased.
As GABAergic inhibitory terminals are known to be pre-
synaptic to the central boutons of type Ia glomeruli [9,36],
it is hypothesized that the GAD65-IR terminals might re-
tract and become lost after glomerular IB4+ central termi-
nals undergo degenerative atrophy. This is supported by
the fact that we found that loss of GAD65-IR terminals
was significantly correlated with the loss of IB4+ terminals
in LII from 5–14 days after cuff placement. Between 14
and 28 days, a time at which both IB4+ and GAD65-IR
terminals were maximally depleted, hypersensitivities
were greatest. It is possible that the disrupted synaptic
organization in the dorsal horn at this time might drive the
development of neuropathic pain. In normal animals, noci-
ceptive information is forwarded to the spinal cord via two
distinct populations of C fibres: the peptidergic and non-
peptidergic. Evidence suggests that nerve injury produces
more profound and longer lasting changes to both the cen-
tral and peripheral terminals of non-peptidergic C fibres in
comparison to the peptidergic population, which appears
to be more resilient [13,37-39]. We suggest that nocicep-
tive information following nerve injury might be preferen-
tially transmitted through the less affected peptidergic
population. Given that peptidergic afferents do not receive
axo- or dendroaxonic synapses from GABAergic neurons
and therefore undergo less direct inhibition [8], it is con-
ceivable that nociceptive signals are more easily transmit-
ted from these remaining peptidergic fibres to projection
neurons. It might be argued as well that as the loss of IB4+
terminals and of GAD65-IR is parallel, the loss of inhib-
ition would be on terminals that disappeared with the le-
sion. However, such reasoning would assume that the
major synaptic targets of GAD65-IR boutons in LIIi are
the central boutons of Type Ia synaptic glomeruli, which is
far from the truth. Indeed, it should be kept in mind that
the great majority of GABA- and glycine-containing termi-
nals are presynaptic to spinal neurons, not to primary af-
ferent terminals [36,40].
In LI, despite the few IB4 fibres that terminate there
[30], the loss and recovery of GAD65 terminals followed
the same time course as within LII, albeit less severe.
These data from LI suggest that it is mostly the inhibi-
tory terminals that contact dorsal horn neurons that are
lost after CCI. In this way, the loss of inhibitory termi-
nals could result in impaired dorsal horn inhibition and
altered nociception.
Finally, we suggest that the amelioration in behaviour
seen at later time points might be in part due to a recov-
ery of the normal synaptic architecture of type Ia glom-
eruli and the reestablishment of an equilibrium between
the peptidergic and non-peptidergic populations. In line
with this idea, regenerative proliferation of IB4+ terminals
is observed after cuff [13], and 40 days after crush injurygrowth cones of primary afferent terminals have been
shown to re-establish synapses with dendritic processes
from substantia gelatinosa neurons [41]. Future studies
using EM would be required to determine if GAD65-IR
terminals resume proper connectivity and presynaptic in-
hibition to non-peptidergic C fibres. Recently it was shown
that when immature GABAergic interneurons were trans-
planted and integrated into spinal cord circuitry, the mech-
anical hypersensitivity associated with SNI was reversed
[42]. These results suggest a potential therapeutic role for
restoring normal inhibitory function in the dorsal horn in
chronic pain conditions.
Conclusions
In this study we show conclusively that GAD65 immuno-
reactivity is transiently lost, suggesting a loss of inhibitory
terminals, in the superficial dorsal horn of the rat spinal
cord following polyethylene cuff-induced lesion of the sci-
atic nerve. The reduction of inhibitory terminals was most
severe in LII and the time course correlated with both the
loss of IB4+ terminals and with the altered thresholds to
both mechanical and thermal stimuli. Further studies are
required to assess whether or not GABAergic terminals
return to their correct location, and re-establish a proper
inhibitory synaptic connectivity with IB4+ central termi-
nals. Additionally, future studies should quantify the pro-
portion of lost inhibitory terminals that were in contact
with IB4+ terminals versus dorsal horn neurons.
Methods
In total, 88 male Wistar rats (200-300 g; Charles River
Canada) were used in this study. Animals were maintained
on a 12:12 hour light: dark cycle and received food and
water ad libitum. Experiments were performed during the
light cycle. All protocols were approved by the McGill
University Animal Care Committee and complied
with the guidelines set by the Canadian Council on
Animal Care and International Association for the Study
of Pain.
Induction of neuropathic pain
Neuropathic pain was induced using a variation of the
Mosconi and Kruger [43] technique. In this model, a
unilateral chronic constriction of the sciatic nerve is
achieved by placing a single polyethylene cuff of fixed
diameter around the nerve [44]. All surgery was done
under aseptic conditions. Animals were anaesthetized
under 5% isoflurane in O2 in an induction chamber, and
maintained at 2.5% isoflurane throughout the remainder
of the surgery. The animals were shaved on their left
side below the pelvis. The left common sciatic nerve was
exposed via blunt dissection through the biceps femoris
muscle. The sciatic nerve was isolated from surrounding
fascia using a glass probe, and a 4-6 mm section of the
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around the nerve. The cuff consisted of a 2 mm piece of
split PE-60 polyethylene tubing with an inner diameter
of 0.76 mm (Intramedic PE-60, Intramedic, Fisher Scientific,
Canada). The muscle and shaved skin layers were closed
separately using 4–0 Vicryl absorbable suture (Ethicon,
Johnson & Johnson, New Jersey, USA) and an antibiotic
ointment was applied. Sham operated rats served as con-
trols, and underwent the same procedure but did not re-
ceive any nerve manipulation. Animals were returned to
their home cages and were allowed to recover for 5 days
before undergoing behavioural testing.
Behavioural testing
Behavioural testing was performed on 20 Wistar rats, 10
cuff and 10 sham animals. Each animal was followed
throughout the following time points: 5, 7, 10, 14, 21,
28, 42 and 56 post surgery.
Mechanical Allodynia
Using the up-down method, responses to mechanical
stimuli were tested with von Frey filaments of increasing
stiffness [45]. Rats were placed in a transparent cage atop
a mesh floor and were allowed to acclimatize for 2 days
prior to baseline testing for 15 minutes each day. Baseline
thresholds were taken 2 days prior to cuff surgery. Von
Frey filaments (0.6, 1, 1.4, 2, 4, 6, 8, 10, 15, 26 g) were ap-
plied serially in ascending order of strength to the plantar
surface of the hindpaw with enough force to elicit a slight
bend in the filament. Each filament was applied for 5 sec-
onds or until a flexion reflex occurred. An acute with-
drawal of the paw was considered a positive response, and
signalled the application of the next weaker filament. In
the absence of a paw withdrawal response, termed a nega-
tive response, the next stronger stimulus was presented.
The resulting pattern of positive and negative responses
was tabulated, where X =withdrawal and 0 = no with-
drawal. The 50% paw withdrawal threshold (grams) was
calculated as (10 [Xf
+ kδ])/10000 where Xf = value (in log
units) of the final von Frey hair used, k = value for the pat-
tern of positive/negative responses and δ =mean differ-
ence in log unit between stimuli (here, δ = 0.224).
Heat Hyperalgesia
The Hargreaves test, which measures the latency of paw
withdrawal from a radiant heat source, was used to as-
sess thermal hyperalgesia [46]. Animals were placed in a
transparent plastic cage on top of a glass plate. For 2 days
prior to baseline testing, animals were habituated to the
apparatus for 15 min each day. On baseline test day,
which occurred 2 days prior to cuff surgery, the plantar
surface of the hindpaw was exposed to a beam of radiant
heat (adjusted to 30% of its maximum) applied through
the glass floor. The light beam is controlled by a photo-cell switch which automatically turns off the light when
the rat lifts its limb. This apparatus allows for the meas-
urement of paw withdrawal latency. To prevent tissue
damage, a cut-off of 20.48 seconds was used. Testing
was performed on both ipsi- and contralateral paws, and
measurements reflect the average of 3 trials, conducted
at 5 minute intervals.
Tissue preparation
A separate group of animals was used for immunohisto-
chemistry. At 5, 7, 10, 14, 21, 42 and 56 days post-surgery,
rats were deeply anaesthetized with Equithesin and transcar-
dially perfused with 4% paraformadehyde (PFA) in 0.1 M
phosphate buffer (PB), pH 7.4, for 30 min. For each time
point, 3–5 sham and 4–8 cuff animals were used. The spinal
cords were removed and post-fixed in 4% PFA for 2 hours
and cryoprotected in 30% sucrose in 0.1 M PB overnight.
The following day, 35 μm transverse sections from the 4th
and 5th lumbar segments (L4 and L5) were cut on a freezing
sledge microtome (SM2000R, Leica Microsystems, Ontario,
Canada) and collected in phosphate-buffered saline (PBS)
containing 0.2% Triton X-100 (PBS-T).
Double labelling
Double labelling immunofluorescence was performed to
explore the changes in GAD65 immunoreactivity both
within and outside of the zone of the IB4 lesion that oc-
curs following CCI. Non-specific staining was blocked
by pre-treatment for 60 minutes with 10% Normal Donkey
Serum (NDS) (Jackson ImmunoResearch, Pennsylvania,
USA) diluted in PBS-T. Sections were then treated with
a mixture of mouse monoclonal anti-GAD-65 antibody
(1:1000, Millipore/Chemicon, Catalog No. MAB351, Lot
No. 0510013666) and IB4 conjugated to Alexa Fluor 488
(1:200, Invitrogen/Molecular Probes; Catalog No. I21411,
Lot No. 38753A) in 5% NDS in PBS-T, and allowed to in-
cubate overnight at 4°C. On day 2, donkey anti-mouse IgG
antibody conjugated to Rhodamine Red X (1:200, Jackson
ImmunoResearch, Catalog No. 715-296-150, Lot No.
70290, 73632) was pre-absorbed with 10 mg/ml of acetone
rat brain powder (Sigma, USA) in 5% NDS for 30 min
at 37°C. This preparation was vortexed every 10 min,
followed by centrifugation at 4000 r.p.m for 20 minutes at
4°C. Following washing, sections were incubated for
2 hours in this mixture. Sections were washed in 0.01 M
PBS, mounted on gelatin-subbed slides, and coverslipped
using Aquapolymount (Polysciences, Pennsylvania, USA).
Quantification of IB4+ non-peptidergic and GAD65+
inhibitory terminals by image analysis
Sections from sham and cuff animals were examined
using a Zeiss LSM 510 confocal scanning laser microscope
(Zeiss Canada) equipped with argon and helium-neon
lasers. Appropriate filters were selected for the separate
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multi-track scanning method. Twelve-bit images were
taken with either a 20X water-immersion or a 63X oil-
immersion objective lens. To ensure consistency among
samples, all parameters of laser power, pinhole size and
image detection were kept unchanged. The chosen param-
eters were set so that the detection of the staining was
maximal while avoiding pixel saturation. For quantifica-
tion, the channels corresponding to each staining were
exported separately as TIFF files. The images were then an-
alyzed with an MCID Elite Image analysis system version 7
(Imaging Research Inc., Ontario, Canada).
Quantitative analysis was performed on 6 tissue sec-
tions from each animal. Analysis was performed within
the region of loss of IB4 staining which occurs predom-
inantly in LII in the intermediate third of the medio-
lateral extent of the dorsal horn. This IB4 lesion is
denoted by a yellow box in Figures 2 and 3. To analyze
the density of IB4- and GAD65-labelled terminals in the
superficial dorsal horn (LI and LII), a rectangle measur-
ing 15 X 40 μm was placed with the longer side at the
edge of the white matter for LI, and a rectangle measur-
ing 30 X 50 μm was placed horizontally at 50 μm from
the white matter within the region of decreased IB4
staining for each animal. On the contralateral side, these
rectangles were placed in a position that mirrored their
location on the ipsilateral side. In sham animals, where
no IB4 lesion is present, these rectangles were placed
where the IB4 lesion normally occurs in neuropathic ani-
mals. The number of IR profiles per unit area was calcu-
lated by the MCID software. To facilitate the detection of
the labelled boutons and to differentiate them from back-
ground, we used a function in the software named “target
accentuate”, which diminishes the overall contrast of the
image but decreases the contrast of smaller structures
(e.g. boutons) to a lesser extent than larger structures. In
order to compensate for failing to count overlapped vari-
cosities, the software performed a correction based on the
average area of each type of varicosity (for IB4 = 0.3 μm2,
for GAD65 bouton = 0.2 μm2), to obtain an estimated
varicosity count. Overlapping boutons were not frequent
with the reduced optical section thickness used. Fur-
thermore, there was no significant difference in aver-
age bouton size from sham and lesioned animals. Most
importantly, the software was set to eliminate punctae
with areas below 0.05 μm2 to ensure that cut axons were
not counted as axonal varicosities. We have used this ap-
proach in other publications see e.g. [47].
Statistical analysis
All values are expressed as a percentage of sham con-
trols; however, statistical analysis was performed using
absolute values. Ipsilateral hindpaw withdrawal thresh-
olds of sham and cuff animals were analyzed using a 2 wayANOVA with a Bonferroni post-hoc test. For immunohis-
tochemistry, the numbers of profiles were statistically ana-
lyzed using a one way ANOVA t-test to compare sham to
cuff animal ipsilateral values. A paired one way ANOVA
t-test was used to compare ipsilateral and contralat-
eral values in each cuff animal. To investigate a correl-
ation between IB4 and GAD65 densities, a non-parametric
Spearman correlation was performed. Significance was set
at p < 0.05.
Antibody specificity and controls
In all immunostainings, omission of primary antibodies
resulted in negative stainings. The anti-GAD65 mono-
clonal antibody recognizes the 65 kDa isoform of GAD,
and was generated by immunizing mice with purified
GAD from rat brain. The mouse anti-GAD65 monoclo-
nal antibody has been well characterized by Chang and
Gottileb where it was shown to specifically recognize rat
GAD65 on Western blots [48]. Atkinson et al. showed
that this monoclonal antibody stained terminals in the
rat central nervous system [49].
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